Skip to main content

Published locations for Few DLBCL patients benefit from nivolumab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Few DLBCL patients benefit from nivolumab

User login

  • Reset your password
  • /content/few-dlbcl-patients-benefit-nivolumab
  • /hematologynews/article/194579/aggressive-lymphomas/few-dlbcl-patients-benefit-nivolumab
  • /oncologypractice/article/194579/aggressive-lymphomas/few-dlbcl-patients-benefit-nivolumab
  • /hematology-oncology/article/194579/aggressive-lymphomas/few-dlbcl-patients-benefit-nivolumab
  • /hematologytimes/article/194579/aggressive-lymphomas/few-dlbcl-patients-benefit-nivolumab
  • /b-cell-lymphoma-icymi/article/194579/aggressive-lymphomas/few-dlbcl-patients-benefit-nivolumab